Brief: Sellas Life Sciences Announces Pricing Of $20 Mln Underwritten Public Offering
24/02/2023 14:05
Feb 24 (Reuters) - Sellas Life Sciences Group Inc
SLS.O :
* SELLAS LIFE SCIENCES ANNOUNCES PRICING OF $20.0 MILLION
UNDERWRITTEN PUBLIC OFFERING
Source text for Eikon: ID:nGNX7dnW56
Further company coverage: SLS.O
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses